Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 494
Immune Disorders Drugs 208
Drug Discovery 169
Cardiovascular Drugs 165
Infectious Diseases Drugs 140
Biopharmaceuticals 131
Clinical Trials 128
Endocrine and Metabolic Disorders Drugs 113
Central Nervous System Drugs 107
Musculoskeletal Disorders Drugs 102
Pharmaceuticals 99
Hematological Drugs 85
Leukemia Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 64
Dermatological Drugs 59
Diabetes Drugs 57
Brain Cancer Drugs 50
Skin Cancer Drugs 50
Respiratory Drugs 45
Mental Disorders Drugs 44
Gastrointestinal Drugs 43
Lung Cancer Drugs 41
Drug Delivery 39
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 36
Pharmaceutical Manufacturing 33
Liver Cancer Drugs 30
Infusions and Injectables 30
Analgesics 27
Bladder Cancer Drugs 26
Antibiotics 26
Drugs by Therapeutic Area 25
Kidney Cancer Drugs 22
HIV/AIDS Drugs 21
Colon Cancer Drugs 20
Pancreatic Cancer Drugs 20
Prostate Cancer Drugs 18
Urological Disorders Drugs 18
Schizophrenia Drugs 17
Ovarian Cancer Drugs 16
Cervical Cancer Drugs 16
Sexual and Reproductive Health Drugs 16
Breast Cancer Drugs 14
Cancer Vaccines 14
Thyroid Cancer Drugs 14
Psoriasis Drugs 14
Over the Counter (OTC) Drugs 11
Biosimilars and Biosuperiors 11
Generic Drugs 10
Vaccines 10
Anti-Obesity Drugs 9
Optical Disorders Drugs 8
Transdermal and Transmucosal Drug Delivery 8
Alzheimer's Disease Drugs 8
Uterine Cancer Drugs 6
Company Reports 5
Pharmacoeconomics 5
Cough and Cold Drugs 5
Anxiety Drugs 4
Vitamins and Dietary Supplements 3
Asthma Drugs 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Allergy Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



275 reviews

2,539 Results (Page 104 of 127)
- Relevance
  Sort by

Oncolytic Virus Cancer Therapy - Pipeline Insight, 2025

 Clinical Trials
April 2025
280 Pages
Global

From

€4431EUR$5,000USD£3,816GBP

Antihyperlipidemic Drugs Market Report and Forecast 2024-2032

 Report
September 2023
160 Pages
Global

From

€3189EUR$3,599USD£2,747GBP

Ischemia Reperfusion Injury Therapeutics Market Report and Forecast 2024-2032

 Report
September 2023
200 Pages
Global

From

€3189EUR$3,599USD£2,747GBP

CAR-T - Pipeline Insight, 2025

 Clinical Trials
April 2025
450 Pages
Global

From

€4431EUR$5,000USD£3,816GBP

Malignant Pleural Mesothelioma- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1772EUR$2,000USD£1,526GBP

NEED HELP FINDING THE RIGHT PRODUCT? Farid will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Cancer Monoclonal Antibody Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

 Report
August 2023
255 Pages
Global

From

€2215EUR$2,500USD£1,908GBP

Biopharmaceuticals Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type and Application

 Report
March 2023
346 Pages
Global

From

€3943EUR$4,450USD£3,396GBP

Rheumatology Therapeutic Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

 Report
February 2024
93 Pages
Global

From

€3500EUR$4,231USD£3,120GBP

Pediatric Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application

 Report
February 2022
103 Pages
Global

From

€3200EUR$3,868USD£2,852GBP

Asia Pacific Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

 Report
April 2023
111 Pages
Asia Pacific

From

€1329EUR$1,500USD£1,145GBP

LAMEA Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

 Report
April 2023
111 Pages
Africa, Middle East

From

€1329EUR$1,500USD£1,145GBP

Europe Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

 Report
April 2023
110 Pages
Europe

From

€1329EUR$1,500USD£1,145GBP

North America Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration (Injectable, and Oral Route), By Distribution Channel, By Country and Growth Forecast, 2023-2029

 Report
April 2023
100 Pages
North America

From

€1329EUR$1,500USD£1,145GBP

Postherpetic Neuralgia - Market Insight, Epidemiology and Market Forecast - 2034

 Report
April 2024
142 Pages
Global

From

€7045EUR$7,950USD£6,067GBP

Anal Fistula Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology

 Report
April 2024
95 Pages
Global

From

€3500EUR$4,231USD£3,120GBP

Precision Cancer Therapeutics, 2022

 Report
November 2022
154 Pages
Global

From

€4431EUR$5,000USD£3,816GBP

Anticancer Drug Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2019-2029F

 Report
May 2024
184 Pages
Global

From

€3390EUR$3,825USD£2,919GBP

€3988EUR$4,500USD£3,434GBP

Phenylketonuria Treatment Market Size Analysis Report - Market Share, Forecast Trends and Outlook (2025-2034)

 Report
June 2025
400 Pages
Global

From

€4386EUR$4,949USD£3,777GBP

CXCR4 Inhibitor - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1329EUR$1,500USD£1,145GBP

Broad Spectrum Chemokine Inhibitor (BSCIs) - Pipeline Insight, 2025

 Clinical Trials
April 2025
90 Pages
Global

From

€1329EUR$1,500USD£1,145GBP

2,539 Results (Page 104 of 127)
- 1
- 102
- 103
- 104
- 105
- 106

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.